November 30, 2022
PAR-20-179 - Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)
PAR-20-180 - Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
The purpose of this notice is to extend the expiration date for PAR-20-179 "Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)" and PAR-20-180 "Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)"
Current Key Dates
Expiration Date: September 08, 2023
Modified Key Dates (in bold italics)
Expiration Date: January 08, 2024
All other aspects of the FOAs remain the same.
Melissa C. Green Parker, PhD
Office of Disease Prevention (ODP)
Telephone: 301-480-1161
Email: [email protected]